Encompass Health Corporation Encompass Health Corporation

Encompass Health Corporation

EHC

Pozycja w akcjach #1704
Encompass Health Corporation delivers a range of post-acute healthcare services... Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Cena akcji
$127.62
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$12.59B
Zmiana (1 dzień)
-0.32%
Zmiana (1 rok)
2.46%
Kraj
US
Handel Encompass Health Corporation (EHC)

Kategoria

Healthcare
Marża operacyjna dla Encompass Health Corporation (EHC)
Marża operacyjna na dzień October 2026 TTM: 18.00%
Według najnowszych raportów finansowych i ceny akcji Encompass Health Corporation, bieżąca marża operacyjna (TTM) wynosi 18.00%. Na koniec 2024 wynosiła 16.09%.
Historia marży operacyjnej dla Encompass Health Corporation od 2000 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 18.00% 40.52%
2025 12.81% -20.39%
2024 16.09% 5.58%
2023 15.24% 5.54%
2022 14.44% -10.14%
2021 16.07% 12.77%
2020 14.25% -10.09%
2019 15.85% -0.56%
2018 15.94% -3.80%
2017 16.57% -6.86%
2016 17.79% 0.00%
2015 17.79% -9.28%
2014 19.61% 15.42%
2013 16.99% -12.24%
2012 19.36% -41.84%
2011 33.29% -49.35%
2010 65.72% 359.26%
2009 14.31% 20.25%
2008 11.90% 10.49%
2007 10.77% 52.33%
2006 7.07% -49.68%
2005 14.05% 126.25%
2004 6.21% -274.93%
2003 -3.55% -116.76%
2002 21.18% -37.11%
2001 33.68% 2.46%
2000 32.87% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
15.48% -99.14%
US
0.00% -
DE
16.80% -99.07%
US
18.67% -98.96%
SA
0.00% -
MY
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.